<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Promising Clinical Results for Lupus Kidney Disease Treatment
Image Overlay - Promising Clinical Results for Lupus Kidney Disease Treatment

Promising Clinical Results for Lupus Kidney Disease Treatment

December 11, 2019

Promising Clinical Results for Lupus Kidney Disease Treatment

Aurinia Pharmaceuticals Inc. announced positive results for its phase III clinical trial for voclosporin, a treatment for active lupus nephritis, a life-threatening complication of lupus. The study met all of its primary and secondary endpoints, leading to complete remission in a signficant number of participants. Yourway is encouraged by this major breakthrough, the first therapy specifically approved for lupus-related kidney disease, and the tremendous benefits it will have for this patient population.

 Back to Index
Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?